The purpose of this study is to i) fabricate a biodegradable nanoparticle formulation of Ketoprofen, ii) 
INTRODUCTION
Ketoprofen is analgesics drug, classified into non-steroidal anti-inflammatory group. It is commonly used to treat rheumatism and arthritis. However, the conventional capsule formulation of Ketoprofen has several disadvantages such as the short half-life, low bioavailability and the side effects [1, 2] .
To overcome these disadvantages, during the last few decades, several new approaches using polymer for preparing Ketoprofen nanoparticles have been studied. Besides thesustained release ability [4] [5] [6] [7] , polymeric nanoparticle formulation presents the drug in very fine nanodroplets offering very high surface area for absorption. This helps with quick absorption of the drug, thus improves oral bioavailability. Moreover, poor permeability is also one of the major factors that limit oral bioavailability of several drugs.
Owing to low bioavailability, some drugs have to be administered at significantly higher doses, whereas the improvement in bioavailability can be translated into reduction in the drug dose and dose-related side effects of many hydrophobic drugs [8] . Most of the current methods described for preparation of polymeric nanoparticles of Ketoprofen used to manufacture drug nanoparticles result in an Science & Technology Development, Vol 16, No.K1-2013 Trang 16 aqueous suspension of nanoparticles [9] .
Suspensions are, however, physically unstable and common problems of suspensions are drug leakage from the particles into water phase, drug degradation, microbiological problems and physical changes such as aggregate formation in the course of time [10] [11] [12] [13] . To increase the physical and chemical stability of the nanoparticles, dry powders would be desirable [11, [14] [15] [16] . Spray drying technique to produce nanoparticle dry powders have been studied. Spray-drying involves the conversion of a solution droplet into a dry particle by evaporation of the solvent in a one-step process [17] [18] [19] . Compared with lyophilized powder obtained from an aqueous suspension, spray dried powders can be prepared without the problems of drug leakage to another phase, and thus, the recovery of drug in the particles is quantitative [17, 20] .
In this work, our laboratory has used successfully spray drying method for preparation of Ketoprofen nanoparticles with Eudragit L100, and the resultant dry powder was studied some characteristics. We pointed out several important chemical and physical
properties of nanoparticles with Transmission
Electron Microscopy (TEM), Scanning Electron Microscopy (SEM). An evaluation of the ability to release the drug at the condition of pH = 1.2 and pH = 7.4 for in vitro studies.Finally, anin vivo assessment of pharmaceutical properties was also conducted.
MATERIALS AND METHODS

Materials
The pharmaceutical drug, Ketoprofen (3- Aerosil -a pharmaceutical excipient used in this research was purchased from GmbH (Germany).
All other chemicals usedwere procured from Merck (Germany).
Preparation of Particles
Nanoparticles containing Ketoprofen and Eudragit L100 were prepared by spray drying method. Briefly,the drug-polymer mixture was prepared by separately dissolving the Eudragit L100 and drug into acetone, using a magnetic stirrer and then mixing the solutions. The ratio of drug and polymer in prepared drug-polymer mixture was 1:3. The continuous process to
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Characterization of Particles
The particle size and morphological examination of the nanoparticles were performed with TEM (JEM 1400, Japan) and
measurements. The samples were placed on carbon-coated copper grids for viewing by TEM. For SEM, the samples from dry powder particles were prepared by gently dipping copper grids into the dry nanoparticles.
2.4.Quantifying Ketoprofen by Highperformance liquid chromatography
Ketoprofen concentration in unlnown samples were also determined by highperformance liquid chromatography (HPLC) using a Nucleosil ODS column (250  4,6 mm; 5 m particle size) at ambient temperature. The mobile phase consisted of 40% Acetonitrile and 60% water containing 1% acid acetic and 0.3% triethylamine. The system was run isocratically at a flow rate of 1.2mL/min.
In vitro dissolution studies
The ultimate aim of this work was to develop sustained release drug delivery system of Ketoprofen. To evaluate this ability, the release tests were performed at both pH conditions in stomach and small intestine. The pH of stomach is acidic, ranging from 1.3 to 5 depending on the fed-fasted conditions. The small intestine has a significantly higher pH level ranging from 6.5 to 7.5 [21].
At each stage, an amount of 100 mg dry powder was weighed and filled into a gelatin capsule. Round-bottomed cylindrical glass vessels having a total volume of 900 mL were used as released chambers. The solutions were kept in a water bath at 37ºC ± 0. 
Drug release from particles
The results of in vitro release study in acidic and basic medium of our Keto-EUD nanoparticles (N20), referential Profenidwere shown in Table 2 and plotted in 
CONCLUSION
We used Eudragit L100 as a matrix polymer to prepare nanoparticle formulation of Release, 57, 115-125 (1999) .
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